Log in to search using one of your social media accounts:

 

The world is running out of antibiotics, WHO says
Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published Tuesday. Adding to the concern: It is likely that the speed of increasing resistance will outpace the slow drug development process. (Source: CNN.com - Health)
Source: CNN.com - Health - September 19, 2017 Category: Consumer Health News Source Type: news

TB: Rapid Test for Multidrug Resistance Shows Promise TB: Rapid Test for Multidrug Resistance Shows Promise
Study results suggest a new rapid test for tuberculosis resistance to multiple drugs could help guide point-of-care treatment and prevent the spread of resistance.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

August ’s top stories: Cancer Research UK’s new oncology trial, Novartis’ malaria drug trial
Cancer Research UK initiated a trial of LY3143921 hydrate to treat patients with advanced solid tumours, and Novartis and MMV initiated a Phase IIb trial of KAF156 to treat multidrug-resistant malaria in Africa. Drugdevelopment-technology.com wraps u … (Source: Drug Development Technology)
Source: Drug Development Technology - September 7, 2017 Category: Pharmaceuticals Source Type: news

The Unexpected and Troubling Rise of Candida auris The Unexpected and Troubling Rise of Candida auris
Behaving like a multidrug-resistant microbe, C auris is spreading rapidly throughout the world, including in healthcare facilities in the United States.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2017 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba(TM)) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
TOKYO, HERTFORDSHIRE, England and PITTSBURGH, Aug. 24, 2017 -- (Healthcare Sales & Marketing Network) -- Otsuka Pharmaceutical Co. Ltd. (Otsuka) and Mylan N.V. (NASDAQ, TASE: MYL) have entered into a license agreement between their respective subsidiaries... Biopharmaceuticals, Licensing Mylan, Otsuka Pharmaceutical, Delamanid, Deltyba (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 24, 2017 Category: Pharmaceuticals Source Type: news

Novartis and MMV initiate Phase IIb trial of KAF156 for malaria in Africa
Novartis and Medicines for Malaria Venture (MMV) have initiated a Phase IIb clinical trial of KAF156 to treat multidrug-resistant malaria in Africa. (Source: Drug Development Technology)
Source: Drug Development Technology - August 21, 2017 Category: Pharmaceuticals Source Type: news

Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria
Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. The trial will test the efficacy of KAF156 in combination with a new, improved formulation of the existing antimalarial lumefantrine. (Source: World Pharma News)
Source: World Pharma News - August 21, 2017 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

‘Superbugs’ found in Brazil’s urban waters
Researchers discover several species of multidrug-resistant bacteria in lakes and rivers of major cities. (Source: SciDev.Net)
Source: SciDev.Net - August 15, 2017 Category: International Medicine & Public Health Source Type: news

Drug Resistant Tuberculosis on the Rise in Eastern Europe Drug Resistant Tuberculosis on the Rise in Eastern Europe
The rapid increase in the epidemic of multidrug-resistant tuberculosis in Eastern Europe is a multifactorial problem, and action is required on many fronts, researchers warn.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Drug-Resistant Tuberculosis on the Rise in Eastern Europe Drug-Resistant Tuberculosis on the Rise in Eastern Europe
The rapid increase in the epidemic of multidrug-resistant tuberculosis in Eastern Europe is a multifactorial problem, and action is required on many fronts, researchers warn.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

TSO3 files FDA app seeking duodenoscope indication for Sterizone VP4 sterilizer
TSO3 said today it filed a 510(k) application with the FDA as it seeks to clear its Sterizone VP4 sterilizer for the terminal sterilization of duodenoscopes used in endoscopic retrograde cholangio-pancreatography procedures. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone for the terminal sterilization of heat and moisture sensitive medical devices. The system has a single pre-programmed cycle which can be used to sterilize a wide range of devices, the Quebec City-based company said. TSO3 said that if awarded, the approval would...
Source: Mass Device - July 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Sterilization / Calibration TSO3 Source Type: news

Nigeria: Govt Adopts Who Guidelines for Multidrug Resistant TB
[Vanguard] The Federal Government has introduced a shorter treatment procedure for Multi-Drug Resistant (MDR) Tuberculosis treatment in Nigeria even as the first Extensively Drug-Resistant TB ward and MDR ward opened at the south west zone TB reference laboratory at the University College Hospital, UCH, Ibadan, Oyo State. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 6, 2017 Category: Infectious Diseases Source Type: news

Tanzania: Drug-Resistant TB Patients Hope for a Shorter Dose
[Citizen] The most common complain of the patients suffering from multidrug resistant tuberculosis (MDR-TB) is the time it takes to finish the medication dosage [the amount of medicine/drug that should be taken during a said period of time]. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 3, 2017 Category: Infectious Diseases Source Type: news

Scary, infectious SUPERBUG just spread to five more U.S. states, including some in the Midwest
(Natural News) A deadly, hard-to-spot “superbug” yeast is rapidly infiltrating American hospitals. In June 2016, the U.S. Centers for Disease Control and Prevention (CDC) warned clinics about the emergence of a new multidrug-resistant yeast strain called Candida auris. Two months later the first seven cases of a C. auris infection were recorded in the United... (Source: NaturalNews.com)
Source: NaturalNews.com - June 21, 2017 Category: Consumer Health News Source Type: news

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis
This Meta-analysis (9,056,241 patient-days and 159 estimates of incidence ratios) found that antibiotic stewardship programmes reduced the incidence of infections and colonisation with multidrug-resistant bacteria and C difficile infections in hospital inpatients. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 20, 2017 Category: Consumer Health News Source Type: news

Former Pfizer Scientist Is Resurrecting Projects To Solve The Multidrug Resistant Bacteria Problem
Despite this success, Dr. Dunne wasn ’t done with Pfizer and his former anti-infective portfolio. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 13, 2017 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE NYSE:AGN Source Type: news

Antibiotic-Associated Adverse Events Common Antibiotic-Associated Adverse Events Common
As many as 20% of hospitalized patients prescribed antibiotics experienced an adverse drug event, including Clostridium difficile or multidrug-resistant organism infection, a new study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 12, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Transmission of Candida auris in US Health Care Facilities Transmission of Candida auris in US Health Care Facilities
This report details the epidemiology of the first seven U.S. cases of infection with the emerging, and often multidrug-resistant, fungus Candida auris.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 9, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

1 in 4 Nursing Home Residents Has Antibiotic-Resistant Bacteria
TUESDAY, May 30, 2017 -- Multidrug-resistant bacteria, such as E. coli, can be found in more than one-quarter of people living in nursing homes, a research review finds. Reviewing eight prior studies, researchers reported rates ranged from 11... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 30, 2017 Category: General Medicine Source Type: news

Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer
Carol Waldo Also Joins Leadership Team as Head of Regulatory Affairs CAMBRIDGE, Mass., May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment o... Biopharmaceuticals, Personnel Spero Therapeutics, multidrug resistant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

DOT Cuts Death During Multidrug Resistant TB Treatment
(MedPage Today) -- U.S. data analysis shows 77% reduction with directly observed therapy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 21, 2017 Category: Primary Care Source Type: news

Directly observed therapy for multidrug-resistant TB decreases mortality
(American Thoracic Society) Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 21, 2017 Category: Infectious Diseases Source Type: news

Superbug grows to 122 cases across 7 states
The number of cases of an emerging and often multidrug-resistant fungus in the United States has grown from seven to 122 over the past nine months, according to a field report in the Morbidity and Mortality Weekly Report issued Thursday by the US Centers for Disease Control and Prevention. (Source: CNN.com - Health)
Source: CNN.com - Health - May 19, 2017 Category: Consumer Health News Source Type: news

Superbug C. auris grows to 122 cases across 7 states, CDC says
The number of cases of an emerging and often multidrug-resistant fungus in the United States has grown from seven to 122 over the past nine months, according to a field report in the Morbidity and Mortality Weekly Report issued Thursday by the US Centers for Disease Control and Prevention. (Source: CNN.com - Health)
Source: CNN.com - Health - May 18, 2017 Category: Consumer Health News Source Type: news

Candida auris: Emerging, Frequently Resistant, and Often Deadly Candida auris: Emerging, Frequently Resistant, and Often Deadly
Given frequent multidrug resistance, what drug therapy is appropriate for treating Candida auris?Medscape Pharmacists (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2017 Category: Consumer Health News Tags: Pharmacist Ask the Expert Source Type: news

Multidrug - Resistant TB Set to Increase Through 2040
Increase in percentage of MDR tuberculosis, XDR tuberculosis in India, Philippines, Russia, S. Africa (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 11, 2017 Category: Respiratory Medicine Tags: Infections, Internal Medicine, Nursing, Pathology, Pulmonology, Journal, Source Type: news

Sewage Saved This Man's Life. Someday It Could Save Yours.
When Thomas Patterson woke up from a two-month coma in March 2016, he learned two things he couldn’t believe: Donald Trump was soon to become the Republican nominee for president, and his wife, Steffanie Strathdee, had saved him from dying of an antibiotic-resistant superbug by injecting him with viruses harvested from sewage. It took a lot of convincing for him to accept these weren’t just more hallucinations. Patterson and Strathdee met while serving on a National Institutes of Health grant review panel almost 16 years ago. Strathdee doesn’t usually find review panels a riveting experience, but when she...
Source: Healthy Living - The Huffington Post - May 11, 2017 Category: Consumer Health News Source Type: news

Sewage Saved This Man's Life. Someday It Could Save Yours.
This article has been updated to amend overstatements of the length of time it took the Texas A&M team to secure the phages they sent to Patterson, as well as the number of researchers to whom Strathdee reached out. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - May 11, 2017 Category: Science Source Type: news

Enterococci may have evolved antimicrobial resistance millions of years ago
(NIH/National Institute of Allergy and Infectious Diseases) Enterococci bacteria are the bane of hospitals, causing thousands of multidrug-resistant infections in patients each year. Now, researchers have traced evidence of the bacteria's evolutionary history back 425 million years and theorize that the same traits that allow the bacteria to thrive in hospitals likely emerged when they were carried onto land in the guts of the world's first terrestrial animals. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 11, 2017 Category: Infectious Diseases Source Type: news

The Deadliest Form Of Tuberculosis Is Snowballing In Countries That Are Already Hard Hit
The deadliest forms of tuberculosis are worsening in four of the countries with the largest number of TB cases, according to a new report in the Lancet Infectious Diseases journal. While tuberculosis, when treated, has an over 83 percent cure rate on average globally, multidrug-resistant TB (MDR-TB), which is resistant to the standard TB antibiotic regimen, has about a 52 percent survival rate if treated. Extensively drug-resistant TB (XDR-TB) has a 28 percent survival rate when treated. Currently, almost 40 percent of all multidrug-resistant tuberculosis cases ― about 230,000 ― occur in Russia, India, t...
Source: Healthy Living - The Huffington Post - May 9, 2017 Category: Consumer Health News Source Type: news

Multidrug-Resistant Mycobacterium tuberculosis: Issues and Controversies
The treatment of tuberculosis is complicated by the emergence of drug resistance. There are several risk factors for developing multidrug-resistant Mycobacterium tuberculosis (MDR-TB) infection, such as patient noncompliance, treatment interruption, and HIV infection. Treatment regimens for MDR-TB infection depend on the results of anti-tuberculous susceptibility testing, as well as consideration of the patient's overall health. Therapy usually consists of a combination of three or more anti-tuberculous agents. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - May 4, 2017 Category: Microbiology Authors: Zeti Norfidiyati Ayub, Habsah Hasan, Siti Suraiya, Mohd Zulfakar Mazlan, Alwi Muhd Besari Tags: Case Report Source Type: news

Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit - Robert A, Danin P É, Quintard H, Degand N, Martis N, Doyen D, Pulcini C, Ruimy R, Ichai C, Bernardin G, Dellamonica J.
BACKGROUND: Pneumonia is one of the major complications of drowning, but the optimal empirical antibiotic treatment is not clearly defined. Multidrug-resistant (MDR) bacteria and fungi have been identified in a recent series of freshwater drowning-associat... (Source: SafetyLit)
Source: SafetyLit - May 2, 2017 Category: Global & Universal Tags: Drowning, Suffocation Source Type: news

A quarter of nursing home residents are colonized with drug-resistant bacteria
The significant presence of multidrug-resistant gram-negative bacteria (MDR-GNB), such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis now published. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 27, 2017 Category: Science Source Type: news

A quarter of nursing home residents are colonized with drug-resistant bacteria
(Elsevier Health Sciences) The significant presence of multidrug-resistant gram-negative bacteria (MDR-GNB), such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis published in the May issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology (APIC). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2017 Category: Infectious Diseases Source Type: news

Novel antibiotic resistance gene in milk
A new antibiotic resistance gene has been found in bacteria from dairy cows. This gene confers resistance to all beta-lactam antibiotics including the last generation of cephalosporins used against methicillin-resistant Staphylococcus aureus. A transfer to S. aureus which is likely according to the researchers would jeopardize the use of reserve antibiotics to treat human infections caused by multidrug-resistant bacteria in hospitals. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 26, 2017 Category: Science Source Type: news

Novel phage therapy saves patient with multidrug-resistant bacterial infection
(University of California - San Diego) Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the US Navy Medical Research Center -- Biological Defense Research Directorate (NMRC-BDRD), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 25, 2017 Category: Infectious Diseases Source Type: news

Biased partitioning of the multidrug efflux pump AcrAB-TolC underlies long-lived phenotypic heterogeneity
We report that AcrAB-TolC, the main multidrug efflux pump of Escherichia coli, exhibits a strong partitioning bias for old cell poles by a segregation mechanism that is mediated by ternary AcrAB-TolC complex formation. Mother cells inheriting old poles are phenotypically distinct and display increased drug efflux activity relative to daughters. Consequently, we find systematic and long-lived growth differences between mother and daughter cells in the presence of subinhibitory drug concentrations. A simple model for biased partitioning predicts a population structure of long-lived and highly heterogeneous phenotypes. This s...
Source: ScienceNOW - April 20, 2017 Category: Science Authors: Bergmiller, T., Andersson, A. M. C., Tomasek, K., Balleza, E., Kiviet, D. J., Hauschild, R., Tkacik, G., Guet, C. C. Tags: Cell Biology reports Source Type: news

A promising strategy to increase activity in antimicrobial peptides
(Institut national de la recherche scientifique - INRS) In an article published recently in Plos One, researchers from INRS-Institut Armand-Frappier Research Centre reported a strategy that could lead to the discovery of new cationic antimicrobial peptides (CAMPs) with greatly enhanced antimicrobial properties. The peptide modified for the study retained considerable activity against biofilms responsible for increasing the severity of various infections. The strategy thus holds promise for combatting multidrug resistant bacteria. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 3, 2017 Category: Global & Universal Source Type: news

Candida auris Further Differentiated: Possible Therapies? Candida auris Further Differentiated: Possible Therapies?
The emerging C auris fungal pathogen is often multidrug resistant and hard to eradicate, but early data suggest it may respond to a new experimental drug.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Infectex reports positive data from Phase IIb-III trial of SQ109 to treat MDR-TB
Russian biotechnology company Infectex has reported positive results from a Phase IIb-III clinical trial of SQ109 to treat patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). (Source: Drug Development Technology)
Source: Drug Development Technology - March 28, 2017 Category: Pharmaceuticals Source Type: news

South Africa to Try Japanese Drug Against Resistant Form of TB South Africa to Try Japanese Drug Against Resistant Form of TB
South Africa launched a new drug programme to treat multidrug-resistant tuberculosis (TB) on Friday in a bid to combat the leading cause of natural deaths in Africa's most industrialised economy.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 27, 2017 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Infectious Diseases A-Z: Rise in multidrug-resistant infections in kids
Multidrug-resistant (MDR) bacterial infections in children are on the rise. A new study shows a 700-percent increase in MDR antibiotic-resistant Enterobacteriaceae infections in children admitted to hospitals around the U.S. "More and more commonly, we are seeing children who are admitted to the hospital, who have infections with more resistant bacteria than we have been [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 27, 2017 Category: Databases & Libraries Source Type: news

The Big Moves This Past Year In The Fight Against the World's Top Infectious Killer
Each year, World Tuberculosis Day brings another reminder that an airborne scourge is the top infectious killer worldwide despite being preventable and curable. An estimated 1.8 million people died in 2015 of the disease, which has a 90 percent cure rate if treated. The growth of drug-resistant strains has experts worried that decades of progress in the fight could be erased. And the World Health Organization estimates there is a $2 billion investment gap in the efforts of low- and middle-income countries to fight tuberculosis each year, as well as a $1.3 billion shortfall in research and development. But despite tho...
Source: Science - The Huffington Post - March 24, 2017 Category: Science Source Type: news

The Big Moves This Past Year In The Fight Against the World's Top Infectious Killer
Each year, World Tuberculosis Day brings another reminder that an airborne scourge is the top infectious killer worldwide despite being preventable and curable. An estimated 1.8 million people died in 2015 of the disease, which has a 90 percent cure rate if treated. The growth of drug-resistant strains has experts worried that decades of progress in the fight could be erased. And the World Health Organization estimates there is a $2 billion investment gap in the efforts of low- and middle-income countries to fight tuberculosis each year, as well as a $1.3 billion shortfall in research and development. But despite tho...
Source: Healthy Living - The Huffington Post - March 24, 2017 Category: Consumer Health News Source Type: news

NIAID Is Dedicated To Saving The Lives Of People With TB
Originally published on niaid.nih.gov Statement of Christine F. Sizemore, PhD., Richard Hafner, M.D., and Anthony S. Fauci, M.D. National Institute of Allergy and Infectious DiseasesNational Institutes of Health Tuberculosis (TB) is one of the world’s most devastating infectious diseases. March 24th marks the day in 1882 when German microbiologist Robert Koch announced he had discovered Mycobacterium tuberculosis, the bacterium that causes this ancient scourge. Today, in recognition of World TB Day, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH)...
Source: Healthy Living - The Huffington Post - March 24, 2017 Category: Consumer Health News Source Type: news

South Africa to try Japanese drug against resistant form of TB
JOHANNESBURG (Reuters) - South Africa launched a new drug program to treat multidrug-resistant tuberculosis (TB) on Friday in a bid to combat the leading cause of natural deaths in Africa's most industrialized economy. (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

One Little Girl Beat The Deadliest Form Of Tuberculosis. She Is Very Lucky.
WASHINGTON ― When Baltimore resident Arjun kisses his 6-year-old daughter’s forehead, it’s not always just a sign of affection. His daughter, Sujata, is onto him. “Is that a temperature kiss?” she asks. Arjun compulsively checks his little girl’s temperature for a reason. Sujata is the survivor of the “first well-described case” of extensively drug-resistant tuberculosis in a young child in the U.S., according to her physicians. Tuberculosis is the world’s biggest killer among infectious diseases, and extensively drug-resistant tuberculosis ― or XDR-TB, which is re...
Source: Healthy Living - The Huffington Post - March 24, 2017 Category: Consumer Health News Source Type: news

One Little Girl Beat The Deadliest Form Of Tuberculosis. She Is Very Lucky.
WASHINGTON ― When Baltimore resident Arjun kisses his 6-year-old daughter’s forehead, it’s not always just a sign of affection. His daughter, Sujata, is onto him. “Is that a temperature kiss?” she asks. Arjun compulsively checks his little girl’s temperature for a reason. Sujata is the survivor of the “first well-described case” of extensively drug-resistant tuberculosis in a young child in the U.S., according to her physicians. Tuberculosis is the world’s biggest killer among infectious diseases, and extensively drug-resistant tuberculosis ― or XDR-TB, which is re...
Source: Science - The Huffington Post - March 24, 2017 Category: Science Source Type: news

New Tuberculosis Drugs May Become Ineffective: Study
A doctor examines the x-ray of a TB patient in New Delhi. Credit: Bijoyeta Das/IPS.By Lyndal RowlandsUNITED NATIONS, Mar 24 2017 (IPS)New antibiotics that could treat tuberculosis may rapidly become ineffective, according to new research published by the Lancet ahead of World Tuberculosis Day.The rise in multi-drug resistant tuberculosis, which affected 480,000 people in 2015, could mean that even newly discovered drugs will soon be useless, the study found.In total both drug resistant and non-drug resistant Tuberculosis (TB) killed an estimated 1.8 million people in 2015, making it the world’s deadliest infecti...
Source: IPS Inter Press Service - Health - March 24, 2017 Category: Global & Universal Authors: Lyndal Rowlands Tags: Featured Headlines Health IPS UN: Inside the Glasshouse Antibiotic Resistance Multidrug-Resistant Tuberculosis (MDR-TB) Source Type: news